Spots Global Cancer Trial Database for Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Official Title: Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Study ID: NCT03413982
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Kansas Medical Center, Kansas City, Kansas, United States
Contact Details
Name: John Taylor, MD
Affiliation: University of Kansas Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
